openPR Logo
Press release

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Poised to Hit $5.19 Billion by 2029 with Accelerating Growth Trends

11-11-2025 05:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Artificial Intelligence AI Powered Chronic Heart Failure Digital Coach Market

Artificial Intelligence AI Powered Chronic Heart Failure Digital Coach Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Size Growth Forecast: What to Expect by 2025?
The market for digital coaching solutions utilizing artificial intelligence for chronic heart failure has experienced remarkable, rapid expansion lately, projecting an increase from its 1.50 billion USD valuation in 2024 to 1.93 billion USD by 2025, reflecting a substantial compound annual growth rate of 28.4%. This escalation observed during the preceding years stems from several key factors, including the growing incidence of persistent heart ailments, heightened public cognizance regarding effective heart disease administration, a greater focus on care models centered around the individual patient, a sharp rise in financial allocations toward managing long-term illnesses, the broader implementation of systems for monitoring patients remotely, and the expanding demographic of older individuals facing elevated cardiovascular vulnerabilities.

How Will the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Size Evolve and Grow by 2029?
The digital coaching market utilizing artificial intelligence (AI) for managing chronic heart failure is projected to experience rapid expansion over the forthcoming years, reaching a valuation of $5.20 billion by 2029, which signifies a compound annual growth rate (CAGR) of 28.1%. This anticipated surge throughout the projection timeframe stems from several factors, including the escalating need for tailored disease management tools, greater emphasis placed on proactive cardiac health strategies, augmented healthcare spending on patient assistance infrastructure, a noticeable increase in the utilization of care delivered at home, the broadening scope of value-based healthcare efforts, and the increasing frequency of hospital admissions linked to cardiovascular ailments. Key movements shaping this period feature progress in how AI engages patients technologically, improvements in using predictive data analysis for earlier identification, novel integrations involving wearable sensors, evolution of interfaces that adapt to different languages, ongoing exploration into customized guidance, and enhancements in processing live data streams.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-chronic-heart-failure-digital-coach-global-market-report

What Drivers Are Propelling the Growth of Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Forward?
Anticipated expansion in the market for AI-driven digital coaching solutions targeting chronic heart failure is being spurred by the escalating impact of cardiovascular ailments. These disorders encompass a spectrum of conditions affecting the heart and vasculature, such as coronary artery disease and issues related to the blood vessels, like cerebrovascular disease. The increasing incidence of these diseases is linked to dietary habits featuring excessive consumption of processed items and sodium, which consequently elevate both blood pressure and cholesterol levels, thereby heightening the risk of heart problems. An advanced digital coach utilizing artificial intelligence assists in managing cardiovascular disease through continuous, real-time health surveillance, delivering tailored recommendations for medication adherence and lifestyle adjustments, all while facilitating swift identification of potential complications and supporting preemptive interventions. To illustrate the scale of this issue, data from the Centers for Disease Control and Prevention (CDC), a key US national public health body, indicated that in October 2024, cardiovascular disease was responsible for 919,032 fatalities across the United States in 2023, translating to roughly one out of every three deaths nationally. Consequently, the mounting challenge posed by cardiovascular diseases serves as a primary catalyst for growth in the sector dedicated to AI-enhanced digital coaching for chronic heart failure patients.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28927&type=smp

Which Emerging Trends Are Transforming the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market in 2025?
Leading corporations within the segment of AI-driven digital coaching for persistent cardiac insufficiency are currently channeling efforts into creating monitoring systems deployable in domestic settings, exemplified by non-surgical platforms for hypertension control aimed at boosting patient compliance with prescriptions and facilitating preemptive condition oversight. These non-invasive systems utilized for managing heart failure are essentially digital instruments employing sensors, personal monitoring devices, and sophisticated AI analysis to follow cardiac performance and vital signs without operative procedures, thereby tracking indicators and directing therapeutic approaches for timely intervention and superior condition governance. Illustratively, in the month of September in the year 2024, Astellas Pharma Inc., originating from Japan, introduced DIGITIVA, a novel, non-intrusive digital well-being product for managing heart failure, which subsequently received documentation from the Food and Drug Administration (FDA); this tool facilitates surveillance of the ailment from home and is engineered around patient-centric care, integrating the CORE 500 Digital Stethoscope, a mobile application leveraging Welldoc's infrastructure, instructional material supplied by the American Heart Association, alongside a specialized clinical assessment group, all working collaboratively toward swift interventions and better patient results, including minimizing sudden crises and inpatient stays.

What Are the Key Segments in the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
The artificial intelligence (ai)-powered chronic heart failure digital coachmarket covered in this report is segmented -

1) By Component: Software, Hardware, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications
4) By End-User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users

Subsegments:
1) By Software: Cloud-Based Platforms, Mobile Applications, Data Analytics Tools, Patient Monitoring Dashboards, Integration Middleware
2) By Hardware: Wearable Devices, Smart Sensors, Connected Medical Devices, Home Monitoring Equipment, Edge Computing Devices
3) By Services: Implementation And Integration Services, Consulting Services, Maintenance And Support Services, Training And Education Services, Remote Patient Monitoring Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28927&type=smp

Who Are the Key Players Shaping the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market's Competitive Landscape?
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, and Implicity SAS.

What Geographic Markets Are Powering Growth in the Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2024. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28927

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Poised to Hit $5.19 Billion by 2029 with Accelerating Growth Trends here

News-ID: 4262910 • Views:

More Releases from The Business Research Company

The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The Market Due To Government-Backed Promotion And Widespread Adoption Of Official Health Apps: Transformative Forces Shaping the Digital Therapeutics For Fibromyalgia Market Landsc
The Growing Awareness Of Digital Health Solutions Is Fueling The Growth Of The M …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Digital Therapeutics For Fibromyalgia Industry Market Size Be by 2025? The market for digital therapeutics tailored to fibromyalgia has experienced rapid expansion lately, projecting an increase from its 2024 valuation of $0.98 billion to $1.19 billion by 2025, demonstrating a considerable compound annual growth rate (CAGR)
Top Market Shifts Transforming the Cosmetic Jars Market Landscape: Key Insights
Top Market Shifts Transforming the Cosmetic Jars Market Landscape: Key Insights
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cosmetic Jars Market Through 2025? The domain encompassing cosmetic jars has experienced substantial expansion lately, projecting a rise from its valuation of $4.55 billion in the year 2024 to an anticipated $4.85 billion by 2025, reflecting a consistent annual growth rate calculation
Global Infrastructure Construction Industry Outlook 2025-2029: Market Set to Cross $4135.29 Billion Milestone
Global Infrastructure Construction Industry Outlook 2025-2029: Market Set to Cro …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Infrastructure Construction Market Size By 2025? The overall scale of the infrastructure construction sector has demonstrated consistent expansion lately, projected to advance from a value of $3,419.01 billion in the year 2024 to reach $3,561.32 billion by 2025, reflecting a compound annual growth rate amounting
Digital Auscultation Market Poised to Hit $1.6 Billion by 2029 with Accelerating Growth Trends
Digital Auscultation Market Poised to Hit $1.6 Billion by 2029 with Accelerating …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Digital Auscultation Market Size Growth Forecast: What to Expect by 2025? The digital auscultation sector has experienced swift expansion lately, projecting an increase from its 2024 valuation of $0.77 billion to $0.89 billion by 2025, reflecting a compound annual growth rate of 16.2%. This demonstrable upswing during the preceding

All 5 Releases


More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after